1. Home
  2. Analysis
  3. Zolpidem-tartrate
  4. Iopamidol

Zolpidem tartrate and Iopamidol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 8 people who take Zolpidem tartrate and Iopamidol. Common interactions include metastases to liver among females, and nausea among males.

The phase IV clinical study analyzes what interactions people who take Zolpidem tartrate and Iopamidol have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

8 people who take Zolpidem tartrate and Iopamidol together, and have interactions are studied.

What is Zolpidem tartrate?

Zolpidem tartrate has active ingredients of zolpidem tartrate. It is used in insomnia. Currently, eHealthMe is studying from 30,436 Zolpidem tartrate users.

What is Iopamidol?

Iopamidol has active ingredients of iopamidol. Currently, eHealthMe is studying from 1,954 Iopamidol users.

Number of Zolpidem tartrate and Iopamidol reports submitted per year:

Zolpidem tartrate and Iopamidol drug interactions.

Common Zolpidem Tartrate and Iopamidol drug interactions by gender *:

female:

  1. Metastases to liver
  2. Pancreatic carcinoma metastatic
  3. Gait disturbance
  4. Malignant ascites
  5. Metastases to kidney
  6. Metastases to lymph nodes
  7. Pleural effusion
  8. Pyelonephritis
  9. Anorexia
  10. Ascites

male:

  1. Nausea
  2. Abdominal pain
  3. Joint contracture
  4. Mobility decreased
  5. Musculoskeletal stiffness
  6. Nephrogenic systemic fibrosis
  7. Oedema peripheral
  8. Pain
  9. Peau d'orange
  10. Skin hyperpigmentation

Common Zolpidem Tartrate and Iopamidol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Metastases to liver
  2. Pancreatic carcinoma metastatic
  3. Pyelonephritis
  4. Anhedonia
  5. Anxiety
  6. Chronic hepatic failure
  7. Emotional distress
  8. Hypoaesthesia
  9. Joint contracture
  10. Mobility decreased

* Approximation only. Some reports may have incomplete information.

Do you take Zolpidem tartrate and Iopamidol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Zolpidem tartrate drug interactions:

Browse interactions between Zolpidem tartrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Iopamidol drug interactions:

Browse interactions between Iopamidol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate and iopamidol (the active ingredients of Zolpidem tartrate and Iopamidol, respectively), and Zolpidem tartrate and Iopamidol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Zolpidem tartrate and Iopamidol.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.